For people living with chronic digestive conditions, the gut is never “just” the gut. It’s the fatigue, the anxiety around meals, and the constant calculation of how food might affect the rest of the day. Over time, gut symptoms stop feeling isolated and begin to influence energy, mood, immune health, and overall quality of life, as ongoing inflammation can contribute to broader disease risk.
This is especially true for people living with inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, conditions driven by ongoing inflammation in the digestive tract. Globally, more than 10 million people live with IBD, while approximately 1 in 10 adults experiences irritable bowel syndrome (IBS). These conditions often require long-term management, and despite advances in treatment, many individuals continue to feel caught in a cycle of flare-ups, symptom management, and uncertainty. Encouragingly, new adjunctive approaches are on the horizon, as researchers explore how nutrition may be utilized alongside standard medical care.
Before diving deeper, it helps to zoom out and look at how the gut connects to, and influences, many other systems throughout the body.
What is the gut–immune connection?
The gut is one of the body’s most active immune organs, housing a significant portion of the immune system. Its role extends beyond absorbing nutrients; it continuously regulates immune responses, determining when inflammation is protective and when it should be dialed down. A healthy gut barrier helps maintain this balance by controlling what passes into circulation and how the immune system responds.
In inflammatory bowel diseases, this balance breaks down. Chronic inflammation can damage the gut lining, disrupt immune signaling, and weaken the intestinal barrier. Over time, inflammation becomes self-perpetuating, no longer responding appropriately to normal regulatory signals. This is why IBD is considered an immune- or autoimmune - driven condition, not simply a digestive disorder.
What has early research shown around nutrition and gut health?
Historically, nutrition was viewed as a way to manage symptoms rather than influence underlying disease mechanisms. That perspective is changing. Researchers are now exploring how specific nutritional patterns may interact with inflammatory pathways, immune regulation, and gut barrier integrity, especially when evaluated alongside standard medical care.
In multiple preclinical studies done in mouse models, researchers examined cycles of the Fasting Mimicking Diet (FMD) on gut inflammation, including colitis and IBD. Across these models, researchers observed overall changes associated with gut health, including reduced gut inflammation, improvements in intestinal barrier function, and shifts in immune signaling related to inflammatory balance.
Is there new research around nutrition, the FMD, and Crohn’s disease?
Expanding on this, and supported by independent research, newly published human data marks an important step forward. In an independent, open-label, randomized clinical trial led by researchers at Stanford University and published in Nature Medicine, three monthly cycles of a five-day Fasting Mimicking Diet (FMD) were evaluated alongside standard medical care in adults with mild-to-moderate Crohn’s disease.
The results were groundbreaking. Researchers reported high rates of clinical response and remission, reductions in markers associated with intestinal inflammation, and improvements observed early in the study period. Notably:
-
Approximately 70% of participants in the FMD group achieved clinical response, and over 60% achieved clinical remission—rates higher than those continuing their baseline diet
-
Improvements were observed early, with many participants showing changes after a single five-day cycle, and were maintained throughout the intervention period.
-
Significant reductions were observed in fecal calprotectin, a marker of intestinal inflammation.
-
Among participants not receiving Crohn’s medications at baseline, response rates were more than twofold higher compared with controls.
-
Changes in inflammatory lipid mediators and immune-related gene expression were consistent with reduced inflammatory activity
This growing body of research reflects a broader shift in how gut health is being understood; not as an isolated system, but as a central pillar of whole-body health. At L-Nutra, we are encouraged by emerging evidence that supports continued investigation into how nutrition may complement existing approaches to inflammatory conditions.
Looking ahead: advancing medical nutrition programs
Building on these findings, L-Nutra Health, our medical division, is developing medical nutrition programs, alongside its metabolic health, prediabetes, and type 2 diabetes programs, that will provide personalized nutritional and lifestyle strategies for autoimmune-related inflammatory bowel conditions. Designed to be complementary therapy alongside lifestyle medicine and standard medical care, these evolving programs continue to translate emerging science into structured, clinically guided approaches.
Visit L-Nutra Health to join the mailing list and stay informed on the program launch.
